SOOLIKANA NEI FOR WHEEZING IN CHILDREN

Phase 2

Not yet recruiting

• Conditions: Moderate persistent asthma,

• Registration Number: CTRI/2022/11/047659
• Lead Sponsor: Government Siddha medical college

Brief Summary

This is a single Non Randomized open Clinical Trial to study the  safety and efficacy of Siddha trial drug Sooli kana nei  (internal) is to be given about 2-5grams twice a day for 14 days to 40 patients.Clinical Trial conducted after conducting Pre Clinical oral toxicity study.The trial drug Sooli kana nei has mentioned in Pillai pini Maruthuvam Part 2.During the trial study related data will be recorded and documented.After the completion of trial all data will be statistically analysed.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-12
• Last Update Posted: 2022-11-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Cough without expectoration Dyspnea Running nose Chest tightness Wheezing.

Exclusion Criteria

Primary complex Hypersensitivity Pneumonitis Lung Abscess Cystic fibrosis Bronchiolitis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is assesed by reduction in clinical symptoms and Modified Asthma Scale before and after treatment	14 days

Secondary Outcome Measures

Name	Time	Method
It is assessed by comparing the safety parameters before and after treatment.	Along with this investigational changesof reduction in ESR level, Eosinophil counts, WBC and increase level of HB

Trial Locations

Locations (1)

Government Siddha medical college; 🇮🇳 Chennai, TAMIL NADU, India

Government Siddha medical college

🇮🇳Chennai, TAMIL NADU, India

Dr Komalesvaran R

Principal investigator

7373942096

komalesvaran2@gmail.com